According to a new research report published by MarketsandMarkets™, titled “Europe Sleep Apnea Devices Market by Product, Age, Gender, and End User – Forecast to 2031” (Report Code: MD 10281), the Europe sleep apnea devices market is projected to grow from USD 1.88 billion in 2026 to USD 2.79 billion by 2031, registering a robust CAGR of 7.4% during the forecast period.
The market was valued at USD 1.76 billion in 2025, reflecting steady momentum driven by the increasing prevalence of obstructive sleep apnea (OSA), rising obesity and cardiovascular disease rates, and growing awareness of the health risks associated with untreated sleep disorders.
Growing Demand for Home-Based Diagnosis and Therapy Fuels Market Expansion
The European sleep apnea devices market is witnessing a strong shift toward home care settings and self-testing, supported by advancements in home sleep testing (HST), digitally enabled positive airway pressure (PAP) devices, and remote patient monitoring solutions. These developments are improving diagnostic accessibility, patient comfort, and long-term therapy compliance.
Therapeutic devices—including CPAP, APAP, and BiPAP systems, masks, oral appliances, and accessories—are expected to register the highest growth rate, driven by improved diagnosis rates and increasing acceptance of long-term sleep apnea therapy across Europe.
Key Market Insights
-
By Product: The therapeutic devices segment is expected to grow at the highest CAGR of 7.5% during the forecast period.
-
By End User: Home care settings and self-testing represent the fastest-growing segment, reflecting patient preference for decentralized and cost-effective care.
-
By Age Group: Individuals aged 40–60 years accounted for 57.5% of the market share in 2025, driven by higher disease prevalence and proactive health screening.
-
By Gender: The male population dominated the market in 2025 due to higher incidence rates of sleep apnea among men.
Germany Leads Growth Across Europe
Germany is projected to be the fastest-growing country market in Europe, supported by strong healthcare infrastructure, increased investment in sleep diagnostics, and widespread adoption of home-based and digitally connected sleep apnea solutions.
Competitive Landscape Highlights
Leading players in the Europe sleep apnea devices market include ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, Inspire Medical Systems, Inc., and SomnoMed. These companies benefit from extensive product portfolios, strong distribution networks, and continuous innovation in connected and patient-centric sleep therapy solutions.
In addition, startups and SMEs such as Compumedics Limited, Löwenstein Medical SE & Co. KG, Drive DeVilbiss International, BMC, and BRAEBON Medical Corporation are strengthening their market presence by addressing specialized niche segments and advancing cost-effective diagnostic and therapeutic technologies.
Technology, Reimbursement, and Awareness Drive Market Momentum
Favorable reimbursement policies in several European countries, along with improved patient awareness and expanding telemedicine infrastructure, are supporting wider adoption of sleep apnea devices. Meanwhile, ongoing innovation in lightweight, ergonomic, and cloud-connected devices is expected to further enhance therapy adherence and long-term outcomes.